CAS RN: 458531-56-1
Carbamic acid, [(1S)-2-hydroxy-1-methyl-3-butenyl]-, 1,1-dimethylethyl ester
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 458531-56-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Hong Kong
Inquiry
458531-56-1 / tert-butyl N-[(2S)-3-hydroxypent-4-en-2-yl]carbamate
Standard CAS: 458531-56-1
Multi CAS: No
Basic Information
copy
CAS
458531-56-1 copy
Multi CAS
No copy
Molecular Formula
C10H19NO3 copy
Molecular Weight
201.260000 copy
Exact Mass
201.136493 copy
InChI
InChI=1S/C10H19NO3/c1-6-8(12)7(2)11-9(13)14-10(3,4)5/h6-8,12H,1H2,2-5H3,(H,11,13)/t7-,8?/m0/s1 copy
InChIKey
WWOUESJNBBFXKX-JAMMHHFISA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Fraction Csp3
0.7 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
55.04 copy
TPSA
58.56 copy
LogP / Solubility
WLOGP
1.45 copy
MLOGP
1.27 copy
XLogP3
1.4 copy
Consensus LogP
1.37 copy
Log S (ESOL)
-1.8 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.25 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.53 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.92 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy